✦ LIBER ✦

88PD EFFICACY AND SAFETY OF ERLOTINIB VERSUS CHEMOTHERAPY IN SECOND-LINE ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) WITH POOR PROGNOSIS: THE PHASE III TITAN STUDY

✍ Scribed by Ciuleanu, T.; Stelmakh, L.; Cicenas, S.; Gonzalez, E. Esteban

Book ID: 118574893
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 74 KB
Volume: 71
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(11)70225-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of erlotinib versus

Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis (TITAN): a randomised multicentre, open-label, phase 3 study

✍ Tudor Ciuleanu; Lilia Stelmakh; Saulius Cicenas; Skaidrius Miliauskas; Alexandru 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 381 KB

Randomized Phase III Trial of Erlotinib

Randomized Phase III Trial of Erlotinib Versus Docetaxel As Second- or Third-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer: Docetaxel and Erlotinib Lung Cancer Trial (DELTA)

✍ Kawaguchi, T.; Ando, M.; Asami, K.; Okano, Y.; Fukuda, M.; Nakagawa, H.; Ibata, 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 183 KB

Randomized, Phase III Study of Gemcitabi

Randomized, Phase III Study of Gemcitabine or Erlotinib Maintenance Therapy Versus Observation, With Predefined Second-Line Treatment, After Cisplatin-Gemcitabine Induction Chemotherapy in Advanced Non-Small-Cell Lung Cancer

✍ Perol, M.; Chouaid, C.; Perol, D.; Barlesi, F.; Gervais, R.; Westeel, V.; Crequi 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 264 KB

Phase I study of second-line chemotherap

Phase I study of second-line chemotherapy with docetaxel and carboplatin in advanced non-small-cell lung cancer

✍ Mikio Oka; Minoru Fukuda; Seiji Nagashima; Masaaki Fukuda; Akitoshi Kinoshita; H 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 84 KB

Efficacy and safety of maintenance erlot

Efficacy and safety of maintenance erlotinib in Asian patients with advanced non-small-cell lung cancer: A subanalysis of the phase III, randomized SATURN study

✍ Wu, Yi-Long; Kim, Joo-Hang; Park, Keunchil; Zaatar, Adel; Klingelschmitt, Gaëlle 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 247 KB

A phase II study of erlotinib in combina

A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancer

✍ Ciuleanu, T.; Tsai, C.-M.; Tsao, C.-J.; Milanowski, J.; Amoroso, D.; Heo, D.S.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 718 KB